The combination of chloroquine and minocycline, a therapeutic option in cerebrospinal infection of Whipple's disease refractory to treatment with ceftriaxone, meropenem and co-trimoxazole

J Antimicrob Chemother. 2012 May;67(5):1295-6. doi: 10.1093/jac/dks008. Epub 2012 Jan 27.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / pharmacology
  • Ceftriaxone / administration & dosage
  • Ceftriaxone / pharmacology
  • Central Nervous System Diseases / drug therapy*
  • Chloroquine / administration & dosage*
  • Chloroquine / pharmacology
  • Drug Resistance, Bacterial
  • Drug Therapy, Combination / methods
  • Humans
  • Male
  • Meropenem
  • Microbial Sensitivity Tests
  • Minocycline / administration & dosage*
  • Minocycline / pharmacology
  • Thienamycins / administration & dosage
  • Thienamycins / pharmacology
  • Trimethoprim, Sulfamethoxazole Drug Combination / administration & dosage
  • Trimethoprim, Sulfamethoxazole Drug Combination / pharmacology
  • Whipple Disease / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Thienamycins
  • Ceftriaxone
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Chloroquine
  • Meropenem
  • Minocycline